Related Experiment Video
Updated: Jan 6, 2026
10:45
Histological Analyses of Acute Alcoholic Liver Injury in Zebrafish
Published on: May 25, 2017
15.0K
Alcohol-related liver disease
Queralt Herms1, Jordi Gratacós-Ginès1,2,3, Elisa Pose1,2,3
1Liver Unit, Hospital Clínic de Barcelona, Barcelona, Spain.
Gastroenterology Report
|October 8, 2025
Summary
Alcohol-related liver disease (ALD) requires comprehensive strategies for diagnosis and treatment. This review covers ALD progression, diagnosis, and interventions for alcohol use disorder, fibrosis, and hepatitis.
Area of Science:
- Hepatology
- Gastroenterology
- Addiction Medicine
Background:
- Alcohol-related liver disease (ALD) is a major global health concern with high mortality.
- ALD encompasses a spectrum of liver damage, from steatosis to cirrhosis and cancer.
- Early detection and intervention are crucial for managing ALD progression.
Purpose of the Study:
- To provide a comprehensive overview of the current state of alcohol-related liver disease (ALD).
- To emphasize diagnostic tools, natural history, and progression factors in ALD.
- To discuss treatment strategies for alcohol use disorder, ALD-related fibrosis, and alcohol-related hepatitis (AH).
Main Methods:
- This review synthesizes current literature on ALD.
- It discusses epidemiology, diagnostic approaches, and prognostic factors.
- Treatment modalities for alcohol use disorder and liver-specific interventions are examined.
Main Results:
- ALD diagnosis and management require tailored strategies for early and advanced stages.
- Effective treatment of alcohol use disorder is pivotal in ALD management.
- Current and future therapeutic options for ALD fibrosis and AH are presented.
Conclusions:
- Comprehensive strategies are needed to enhance diagnosis and prognostic stratification for ALD.
- Integrated approaches are essential for improving treatment outcomes at all stages of ALD.
- Further research into novel therapeutic targets for ALD is warranted.
More Related Videos
Related Concept Videos
01:26Diseases of the Liver and Gallbladder
1.8K
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
1.8K
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
157
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
157
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
193
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
193
01:24Chronic Pancreatitis I: Introduction
643
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
643
01:08Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
234
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
234
01:30Liver Physiology
3.4K
The liver, an essential organ in the human body, performs over 200 vital functions that can be broadly categorized into metabolic, hematological, endocrine regulation, and bile production.
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
3.4K